PET Image Quantification

Assess FDG PET/CT study comparability using glucose-aware quantitative standards.

Glucose Context (SUV Support)

Context-aware assessment of how glucose level, uptake time, and dose timing may influence SUV comparability.

Blood Glucose (mg/dL) Uptake Time (minutes) FDG Dose (mCi) Diabetic patient

Provides acquisition context only. Does not modify SUV values or replace clinical judgment.

How this is used: The glucose-aware context above is applied as acquisition support when interpreting the quantitative assessment below. OraQuant remains rule-based and authoritative.

OraQuant — Full Quantitative Assessment

OraQuant is a quantitative assessment tool designed to help imaging professionals evaluate FDG PET/CT study comparability using glucose-aware, time-aware standards.

Supports quantitative interpretation by assessing glucose level, uptake time, and dose timing consistency.
Designed for use before or during image review to understand potential sources of SUV variability.
Aligns with guidance from SNMMI, EANM, PERCIST, and ACR-aligned quantitative best practices.

Evaluation mode: OraQuant provides rule-based quantitative context and optional AI-assisted explanations. It does not generate clinical recommendations or replace professional judgment.

Data handling: This tool is intended for educational and workflow support. Do not enter patient identifiers or protected health information (PHI).

Study Inputs

Patient Weight

Unit

Patient Height

Unit

Metric: —

FDG Dose (mCi) Measured SUV (optional) Injection Time

Uptake Time (minutes)

Blood Glucose (mg/dL) Fasting Status Fasting Duration (hours)

Diabetic Patient? If diabetic: insulin within last 6 hours? Glucose Measurement Time

Quantitative Assessment

Loading PET Quant rules…